title: Fatal aseptic meningoencephalitis following infliximab treatment for inflammatory bowel disease.
authors.forename: R
authors.initials: R
authors.lastname: Quispel
authors.forename: H B
authors.initials: HB
authors.lastname: van der Worp
authors.forename: M
authors.initials: M
authors.lastname: Pruissen
authors.forename: M E
authors.initials: ME
authors.lastname: Schipper
authors.forename: B
authors.initials: B
authors.lastname: Oldenburg
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D017809:Fatal Outcome; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab; D008297:Male; D008590:Meningoencephalitis / Q000209:etiology*; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab